| P50 | author | Jinsong Bian | Q73151602 |
| | Xu Cao | Q88670371 |
| P2093 | author name string | Xu Cao | |
| | Jin-Song Bian | |
| P2860 | cites work | Interaction of Hydrogen Sulfide with Nitric Oxide in the Cardiovascular System | Q26774063 |
| | Acute nephrotoxicity of cisplatin: molecular mechanisms | Q27011912 |
| | H2S as a physiologic vasorelaxant: hypertension in mice with deletion of cystathionine gamma-lyase | Q28298435 |
| | Human NIMA-related kinase 6 is one of the Fe65 WW domain binding proteins | Q28303174 |
| | Murine cystathionine gamma-lyase: complete cDNA and genomic sequences, promoter activity, tissue distribution and developmental expression | Q28506768 |
| | 3-Mercaptopyruvate sulfurtransferase produces hydrogen sulfide and bound sulfane sulfur in the brain | Q28513550 |
| | Hyperhomocysteinemia associated with decreased renal transsulfuration activity in Dahl S rats | Q28564507 |
| | Endogenous or overexpressed cGMP-dependent protein kinases inhibit cAMP-dependent renin release from rat isolated perfused kidney, microdissected glomeruli, and isolated juxtaglomerular cells | Q28564609 |
| | Characterization of homocysteine metabolism in the rat kidney | Q28568553 |
| | Peroxynitrite: biochemistry, pathophysiology and development of therapeutics | Q29615424 |
| | Hydrogen sulfide-induced hypometabolism prevents renal ischemia/reperfusion injury | Q30489935 |
| | Hydrogen sulfide (H2S) metabolism in mitochondria and its regulatory role in energy production | Q30505673 |
| | Hydrogen sulfide as an oxygen sensor/transducer in vertebrate hypoxic vasoconstriction and hypoxic vasodilation | Q33259496 |
| | Hydrogen sulfide inhibits the renal fibrosis of obstructive nephropathy | Q33696105 |
| | Increased adrenal renin in transgenic hypertensive rats, TGR(mREN2)27, and its regulation by cAMP, angiotensin II, and calcium | Q33892084 |
| | The slow-releasing hydrogen sulfide donor, GYY4137, exhibits novel anti-cancer effects in vitro and in vivo | Q33942063 |
| | Hydrogen sulfide inhibits plasma renin activity | Q33979335 |
| | Hypertensive nephropathy: prevention and treatment recommendations | Q34131899 |
| | Two's company, three's a crowd: can H2S be the third endogenous gaseous transmitter? | Q34157091 |
| | Effects of hydrogen sulphide in an experimental model of renal ischaemia-reperfusion injury. | Q51298127 |
| | GYY4137, a Slow-Releasing Hydrogen Sulfide Donor, Ameliorates Renal Damage Associated with Chronic Obstructive Uropathy. | Q51753012 |
| | Novel hydrogen sulfide-releasing compound, S-propargyl-cysteine, prevents STZ-induced diabetic nephropathy. | Q53127535 |
| | Correlation of lower concentrations of hydrogen sulfide with atherosclerosis in chronic hemodialysis patients with diabetic nephropathy. | Q53662047 |
| | Clinical aspects of hydrogen sulfide poisoning | Q53978368 |
| | Rescue of mesangial cells from high glucose-induced over-proliferation and extracellular matrix secretion by hydrogen sulfide. | Q54394118 |
| | Acute kidney injury | Q61361815 |
| | Monoamine oxidase inhibition as a sequel of hydrogen sulfide intoxication: increases in brain catecholamine and 5-hydroxytryptamine levels | Q69625532 |
| | Hydrogen sulphide regulates intracellular pH in vascular smooth muscle cells | Q80389174 |
| | Hydrogen sulfide (H₂S) and hypoxia inhibit salmonid gastrointestinal motility: evidence for H₂S as an oxygen sensor | Q82445619 |
| | Hydrogen sulfide as an endothelium-derived hyperpolarizing factor in rodent mesenteric arteries | Q83186438 |
| | Exogenous hydrogen sulfide (H2S) reduces blood pressure and prevents the progression of diabetic nephropathy in spontaneously hypertensive rats | Q83197700 |
| | [Role of hydrogen sulfide in chronic kidney disease and diabetic nephropathy] | Q83199245 |
| | Effects of intravenous sulfide during porcine aortic occlusion-induced kidney ischemia/reperfusion injury | Q84596416 |
| | Hydrogen sulfide regulates cAMP homeostasis and renin degranulation in As4.1 and rat renin-rich kidney cells | Q84975272 |
| | Hydrogen sulphide and tempol treatments improve the blood pressure and renal excretory responses in spontaneously hypertensive rats | Q87243801 |
| | Detrimental effects of prolonged warm renal ischaemia-reperfusion injury are abrogated by supplemental hydrogen sulphide: an analysis using real-time intravital microscopy and polymerase chain reaction | Q87418850 |
| | Hydrogen sulfide treatment reduces blood pressure and oxidative stress in angiotensin II-induced hypertensive mice | Q87515276 |
| | Sulfur amino acid metabolism: pathways for production and removal of homocysteine and cysteine | Q34326009 |
| | Hydrogen sulfide targets EGFR Cys797/Cys798 residues to induce Na(+)/K(+)-ATPase endocytosis and inhibition in renal tubular epithelial cells and increase sodium excretion in chronic salt-loaded rats | Q34431778 |
| | Chronic kidney disease | Q34631631 |
| | Hydrogen sulfide prevents hydrogen peroxide-induced activation of epithelial sodium channel through a PTEN/PI(3,4,5)P3 dependent pathway | Q34760443 |
| | Actions and interactions of nitric oxide, carbon monoxide and hydrogen sulphide in the cardiovascular system and in inflammation--a tale of three gases! | Q34984278 |
| | H(2)S inhibits hyperglycemia-induced intrarenal renin-angiotensin system activation via attenuation of reactive oxygen species generation | Q34994649 |
| | Hydrogen Sulfide Epigenetically Attenuates Homocysteine-Induced Mitochondrial Toxicity Mediated Through NMDA Receptor in Mouse Brain Endothelial (bEnd3) Cells | Q35009206 |
| | Hydrogen sulfide as an oxygen sensor | Q35015679 |
| | Hydrogen sulfide as endothelium-derived hyperpolarizing factor sulfhydrates potassium channels | Q35603720 |
| | Hydrogen Sulfide Donor GYY4137 Protects against Myocardial Fibrosis. | Q35640723 |
| | Hydrogen Sulfide Prevents Advanced Glycation End-Products Induced Activation of the Epithelial Sodium Channel | Q35640767 |
| | GYY4137 protects against myocardial ischemia and reperfusion injury by attenuating oxidative stress and apoptosis in rats | Q35666649 |
| | Targeting NADPH oxidase with a novel dual Nox1/Nox4 inhibitor attenuates renal pathology in type 1 diabetes | Q35671828 |
| | Interdependency of cystathione γ-lyase and cystathione β-synthase in hydrogen sulfide-induced blood pressure regulation in rats | Q35671857 |
| | Hydrogen sulfide inhibits high glucose-induced matrix protein synthesis by activating AMP-activated protein kinase in renal epithelial cells | Q35763027 |
| | Pathophysiology of hypertensive renal damage: implications for therapy | Q35903433 |
| | Toxicology of Hydrogen Sulfide | Q36213459 |
| | AP39, A Mitochondrially Targeted Hydrogen Sulfide Donor, Exerts Protective Effects in Renal Epithelial Cells Subjected to Oxidative Stress in Vitro and in Acute Renal Injury in Vivo | Q36385235 |
| | Distribution of hydrogen sulfide (H₂S)-producing enzymes and the roles of the H₂S donor sodium hydrosulfide in diabetic nephropathy | Q36609773 |
| | Hydrogen sulfide (H2S) - the third gas of interest for pharmacologists. | Q36766304 |
| | Cystathionine γ-lyase protects against renal ischemia/reperfusion by modulating oxidative stress | Q36796570 |
| | Hydrogen sulfide deficiency and diabetic renal remodeling: role of matrix metalloproteinase-9. | Q36923702 |
| | Renin release | Q36967632 |
| | Hydrogen sulphide and its therapeutic potential | Q36975742 |
| | A H 2 S Donor GYY4137 Exacerbates Cisplatin-Induced Nephrotoxicity in Mice. | Q37000218 |
| | Oxygen-sensitive mitochondrial accumulation of cystathionine β-synthase mediated by Lon protease | Q37068583 |
| | Cisplatin nephrotoxicity: mechanisms and renoprotective strategies | Q37084089 |
| | The pathogenesis of diabetic nephropathy | Q37209550 |
| | Potential biological chemistry of hydrogen sulfide (H2S) with the nitrogen oxides | Q37233345 |
| | No facilitator required for membrane transport of hydrogen sulfide | Q37377256 |
| | Ischemia and reperfusion--from mechanism to translation | Q37455225 |
| | Hydrogen sulfide: a new EDRF. | Q37523189 |
| | Hydrogen sulfide and oxygen sensing in the cardiovascular system | Q37608289 |
| | Hydrogen sulfide attenuates sFlt1-induced hypertension and renal damage by upregulating vascular endothelial growth factor | Q37670305 |
| | Hydrogen sulfide: its production, release and functions | Q37700262 |
| | Renal fibrosis: novel insights into mechanisms and therapeutic targets. | Q37788542 |
| | Hydrogen sulfide: advances in understanding human toxicity | Q37809419 |
| | Hydrogen sulfide in the mammalian cardiovascular system. | Q37981269 |
| | The physiological role of hydrogen sulfide and beyond | Q38184673 |
| | H2S, a novel therapeutic target in renal-associated diseases? | Q38242391 |
| | Hydrogen sulfide: a neuromodulator and neuroprotectant in the central nervous system | Q38250429 |
| | Hydrogen sulfide in renal physiology, disease and transplantation--the smell of renal protection. | Q38345808 |
| | Hydrogen sulfide-based therapeutics: exploiting a unique but ubiquitous gasotransmitter | Q38409371 |
| | Protective effect of hydrogen sulfide on renal injury in the experimental unilateral ureteral obstruction | Q38532256 |
| | Hydrogen Sulfide in Renal Physiology and Disease | Q38785627 |
| | Intramitochondrial hydrogen sulfide production by 3-mercaptopyruvate sulfurtransferase maintains mitochondrial electron flow and supports cellular bioenergetics | Q39252442 |
| | Vasoconstrictive effect of hydrogen sulfide involves downregulation of cAMP in vascular smooth muscle cells. | Q39940764 |
| | High urinary sulfate concentration is associated with reduced risk of renal disease progression in type 2 diabetes | Q39940998 |
| | Hydrogen sulfide inhibits nitric oxide production and nuclear factor-kappaB via heme oxygenase-1 expression in RAW264.7 macrophages stimulated with lipopolysaccharide | Q40266368 |
| | Administration of hydrogen sulfide protects ischemia reperfusion-induced acute kidney injury by reducing the oxidative stress. | Q40770083 |
| | Hydrogen sulfide poisoning | Q41495573 |
| | Hydrogen sulfide alleviates diabetic nephropathy in a streptozotocin-induced diabetic rat model | Q41856390 |
| | Characterization of the enzymic capacity for cysteine desulphhydration in liver and kidney of the rat | Q42122753 |
| | Effects of hydrogen sulfide on high glucose-induced glomerular podocyte injury in mice | Q42224620 |
| | Effect of synthesized GYY4137, a slowly releasing hydrogen sulfide donor, on cell viability and distribution of hydrogen sulfide in mice | Q42855069 |
| | Bicarbonate-dependent effect of hydrogen sulfide on vascular contractility in rat aortic rings. | Q42957510 |
| | Inhibition of hydrogen sulphide formation reduces cisplatin-induced renal damage | Q42959201 |
| | Hypoxia in the renal medulla: implications for hydrogen sulfide signaling. | Q43081728 |
| | Hydrogen sulfide ameliorates the kidney dysfunction and damage in cisplatin-induced nephrotoxicity in rat. | Q43085121 |
| | Production and actions of hydrogen sulfide, a novel gaseous bioactive substance, in the kidneys | Q43125231 |
| | Erratum to: Combined effect of hydrogen sulphide donor and losartan in experimental diabetic nephropathy in rats | Q43203062 |
| | Urinary sulphate excretion and progression of diabetic nephropathy in Type 1 diabetes. | Q43966303 |
| | A novel pathway for the production of hydrogen sulfide from D-cysteine in mammalian cells | Q44131370 |
| | Exogenous hydrogen sulfide prevents kidney damage following unilateral ureteral obstruction | Q45383155 |
| | Downregulation of the renal and hepatic hydrogen sulfide (H2S)-producing enzymes and capacity in chronic kidney disease. | Q45986959 |
| | Ischemia-reperfusion reduces cystathionine-beta-synthase-mediated hydrogen sulfide generation in the kidney. | Q46013974 |
| | Characterisation of cystathionine gamma-lyase/hydrogen sulphide pathway in ischaemia/reperfusion injury of the mouse kidney: an in vivo study. | Q46046894 |
| | H2S donors attenuate diabetic nephropathy in rats: Modulation of oxidant status and polyol pathway. | Q46247471 |
| | Endogenous hydrogen sulfide is involved in regulation of respiration in medullary slice of neonatal rats. | Q46365987 |
| | Generation of endogenous hydrogen sulfide by cystathionine gamma-lyase limits renal ischemia/reperfusion injury and dysfunction | Q46446506 |
| | The possible role of hydrogen sulfide as an endogenous neuromodulator. | Q46606180 |
| | Characterization of a novel, water-soluble hydrogen sulfide-releasing molecule (GYY4137): new insights into the biology of hydrogen sulfide | Q46621665 |
| | Hydrogen sulfide accelerates the recovery of kidney tubules after renal ischemia/reperfusion injury | Q46705377 |
| | Negative regulation of beta-adrenergic function by hydrogen sulphide in the rat hearts | Q46711765 |
| | Pathogenesis, prevention, and treatment of diabetic nephropathy | Q47770839 |
| | Inhibition of respiratory and bioenergetic mechanisms by hydrogen sulfide in mammalian brain | Q47854783 |
| | Characteristics of the enzymatic capacity for cysteine desulfhydration in cat tissues | Q49079554 |
| | H₂S is an endothelium-derived hyperpolarizing factor. | Q51272873 |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 385 | |
| P577 | publication date | 2016-10-18 | |
| P1433 | published in | Frontiers in Pharmacology | Q2681208 |
| P1476 | title | The Role of Hydrogen Sulfide in Renal System | |
| P478 | volume | 7 | |